![]() | |
Clinical data | |
---|---|
Dependence liability | Moderate |
Routes of administration | Oral, sublingual, rectal |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H13ClN4S |
Molar mass | 328.82 g·mol−1 |
3D model (JSmol) | |
| |
|
Metizolam (also known as desmethyletizolam) is a thienotriazolodiazepine that is the demethylated analogue of the closely related etizolam.[1][2][3][4][5][6]
Following its sale as a designer drug,[7] metizolam was classified as controlled substance in Sweden on 26. January 2016.[8]
| |||||
---|---|---|---|---|---|
PAFRTooltip Platelet-activating factor receptor |
| ||||
Others |
| ||||
|
![]() | This sedative-related article is a stub. You can help Wikipedia by expanding it. |